Why is phosphorylation important in biochemistry

Localized dimerization and nucleoid binding drive gradient formation by the bacterial cell division inhibitor MipZ. Kirkpatrick, C. Cell polarity: ParA-logs gather around the Hub.

Kobir, A. Kozlov, A. Intrinsically disordered C-terminal tails of E. Kuzminov, A. DNA replication meets genetic exchange: chromosomal damage and its repair by homologous recombination. Langston, L. Whither the replisome: emerging perspectives on the dynamic nature of the DNA replication machinery. Cell Cycle 8, — DNA replication: keep moving and don't mind the gap.

Cell 23, — Lecointe, F. Lee, H. Cell Res. Lin, W. Optimization of titanium dioxide enrichment of phosphopeptides and application in the Thermoanaerobacter tengcongensis phosphoproteome analysis. Se Pu 30, — Lutkenhaus, J. Trends Microbiol. Maathuis, F. Conservation of protein phosphorylation sites within gene families and across species.

Plant Signal. Macek, B. Phosphoproteome analysis of E. Proteomics 7, — Proteomics 6, — Manteca, A. Phosphoproteome analysis of Streptomyces development reveals extensive protein phosphorylation accompanying bacterial differentiation. Manuse, S. Marchadier, E. An expanded protein-protein interaction network in Bacillus subtilis reveals a group of hubs: exploration by an integrative approach.

Merrikh, H. Replication-transcription conflicts in bacteria. Mettrick, K. Stability of blocked replication forks in vivo. Mijakovic, I. Bacterial single-stranded DNA-binding proteins are phosphorylated on tyrosine. Misra, S. Nakedi, K. Nourikyan, J. Autophosphorylation of the bacterial tyrosine-kinase CpsD connects capsule synthesis with the cell cycle in Streptococcus pneumoniae.

Oakley, G. Replication protein A: directing traffic at the intersection of replication and repair. Biochemistry 42, — Ortega, C. PLoS Biol. Pan, Z. Database bav Pereira, S. Perry, S. Pini, F. Pomerantz, R. What happens when replication and transcription complexes collide? Cell Cycle 9, — Pompeo, F. Phosphorylation of the cell division protein GpsB regulates PrkC kinase activity through a negative feedback loop in Bacillus subtilis. Prisic, S. Ravichandran, A.

Proteomics 9, — Ravikumar, V. Quantitative phosphoproteome analysis of Bacillus subtilis reveals novel substrates of the kinase PrkC and phosphatase PrpC. Proteomics 13, — Schmidl, S. Sclafani, R. Cell cycle regulation of DNA replication. Shechter, D. DNA Repair 3, — Shi, L. Protein-tyrosine phosphorylation interaction network in Bacillus subtilis reveals new substrates, kinase activators and kinase cross-talk. Soares, N. Global dynamics of the Escherichia coli proteome and phosphoproteome during growth in minimal medium.

Soufi, B. Proteomics 8, — Subramanian, V. The meiotic checkpoint network: step-by-step through meiotic prophase. Cold Spring Harb. Sun, X. Phosphoproteomic analysis reveals the multiple roles of phosphorylation in pathogenic bacterium Streptococcus pneumoniae. Takahata, Y. Close proximity of phosphorylation sites to ligand in the phosphoproteome of the extreme thermophile Thermus thermophilus HB8. Proteomics 12, — Thanbichler, M. MipZ, a spatial regulator coordinating chromosome segregation with cell division in Caulobacter.

Treuner-Lange, A. Regulation of cell polarity in bacteria. Truong-Bolduc, Q. Posttranslational modification influences the effects of MgrA on norA expression in Staphylococcus aureus. Voisin, S. The cytoplasmic phosphoproteome of the Gram-negative bacterium Campylobacter jejuni: evidence for modification by unidentified protein kinases. Vujaklija, D. Detecting posttranslational modifications of bacterial SSB proteins.

Methods Mol. Wright, D. Regulation of transcription by eukaryotic-like serine-threonine kinases and phosphatases in Gram-positive bacterial pathogens. Virulence 5, — Wu, L. RacA and the Soj-Spo0J system combine to effect polar chromosome segregation in sporulating Bacillus subtilis.

Xenopoulos, P. Regulation of growth of the mother cell and chromosome replication during sporulation of Bacillus subtilis. Yadav, T. Genetic recombination in Bacillus subtilis : a division of labor between two single-strand DNA-binding proteins.

Yang, M. Zeke, A. Scaffolds: interaction platforms for cellular signalling circuits. Trends Cell Biol. In chronic myeloid leukemia, a particular chromosomal translocation Philadelphia chromosome was identified that generates a novel kinase that is always active, the retinoblastoma, pRb. The process normally controlled by this kinase is stuck in the 'on' position. This leads to the proliferation of tumor cells Stehelin was one of the first researchers to understand the direct involvement of protein kinases in tumors, with the study of the oncogene v-SRC This tyrosine kinase with the phosphate group of Tyr has a key role in tumor cell proliferation, and has been studied extensively in Rous sarcoma virus RSV as the main cause of sarcoma in chickens 89 — Its carcinogenic action is due to a mutation of the carboxyl terminal of the molecule able to eliminate the tyrosine residue, which causes conformational changes and also an irregular unregulated autophosphorylation, leading to a signal of increased growth 93 , Aberrations of kinases have been reported in different types of cancer.

Phosphorylation plays a key role even in oral cancer. Endothelial growth factor receptor EGFR signaling. Ligand binding to the EGFR activates its intrinsic tyrosine kinase activity. Alteration of the phosphoproteome also affects gastrointestinal stromal tumors GISTs 98 , 99 , lung cancer 73 , , hematologic malignancies , , breast cancer , , pancreatic cancer , and prostate cancer , To date, more than 1, variations in the expression of protein kinases have been detected in human tumors — In tumors, mTOR Fig.

The Ras oncogene Fig. It begins with the binding of a ligand to a receptor tyrosine kinase RTK loca ted on the plasma membrane. This receptor is activated only if it dimerizes with another RTK. They then phosphorylate each other and become activated.

The activated receptor binds to the SH2 domain of the adapter protein Grb2, which plays its role without being phosphorylated. The signaling pathways regulated by protein kinases contribute to the onset and progression of almost all types of cancer. Consequently, research of the signaling pathways mediated by kinase and therefore the possibility of blocking them with targeted treatment could have major clinical-therapeutic utility especially since many of these proteins act as oncogenes 78 , , Considerable advances have led to the identification of inhibitors directed against activated tyrosine kinases in cancer, 17 of which are already used for the treatment of several cancers and more than molecules are being tested If overexpressed, HER2 is a protein tyrosine kinase which enhances the proliferation of cancer cells, and enhances the formation of blood vessels thereby increasing the invasiveness of breast cancer.

The simultaneous inhibition of these targets induces a reduction in tumor vascularization and triggers cancer cell apoptosis. It has been recommended as a drug in renal cell carcinoma and in GISTs , Furthermore, since sunitinib targets many different receptors, it leads to dermatologic toxic side effects such as hand-foot syndrome Temsirolimus leads to cell cycle arrest in the G1 phase, and also inhibits tumor angiogenesis by reducing synthesis of VEGF The success of therapies based on kinase inhibitors relies on different aspects: the clinical targeted kinase, the structure of the signaling network and the mechanisms of innate or acquired resistance.

First of all, both the patients and the therapeutic approach functions must be appropriately selected However, not all tumors respond to inhibitors of kinases and often patients with the same cancer respond differently to the same therapy. For this reason, patients should be further stratified using biomarkers and further studies are warranted to investigate the signaling pathways — In this respect, we know that changes in the signaling pathways, caused by several factors genetic and epigenetic mutations, alterations of the microenvironment , lead to the formation of oncogenes and, very often, there is a release of tumoral molecules that can be tracked and used as biomarkers.

The signaling networks of cancer cells can also develop innate or acquired resistance, since they are able to create the most common or rare oncogenic mutations different from tumor to tumor the so-called polygenic tumor biology There are two main types of resistance to a drug treatment based on kinase inhibitors. Intrinsic or innate resistance on target occurs when the drug target protein has changed due to steric hindrance to inhibitor binding , altered active site topography , disruption of favorable inhibitor interactions , altered protein dynamics , increased oncogenicity , and alteration of ATP affinity In this way, this resistance is not inhibited by the drug and continues to perform its normal activity in the tumor cell.

The cancer cells are able in fact to exploit and reactivate the mechanism of signaling that the drug would inhibit In addition, during treatment acquired resistance can occur and the tumors can develop subclones which foster even relapse. New studies of the signaling network of tumors with particular attention to the mechanism of action of drug inhibitors of protein kinases are therefore needed. Phosphoproteomics has a critical relevance for many aspects of biology and has a significant role for understanding the molecular mechanisms, especially those that lead to the genesis and growth of tumors 77 — Signaling networks in which protein kinases operate are highly complex, but we believe that understanding the regulatory functions of kinases may be a valid means to identify more effective therapies against cancer , Many drug kinase inhibitors are already on the market , — but, often, their effectiveness is reduced due to the development of complex mechanisms of drug resistance However, great progress has been made in recent years thanks to the numerous techniques of proteomics.

Proteomics is the most important way by which to study the sites and behavior of phosphoprotein and phosphosite in tumor biology. The identification of biomarkers that aid in the selection of the most appropriate therapy for individual patients remains a major challenge National Center for Biotechnology Information , U. Int J Mol Med. Published online Jun Author information Article notes Copyright and License information Disclaimer. Received Jan 17; Accepted May This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

This article has been cited by other articles in PMC. Keywords: protein phosphorylation, kinase, phosphatase, phospho-signaling networks, cancer, drug target. Introduction Protein phosphorylation is one of the most common and important post-translational modifications PTMs 1 , 2.

Open in a separate window. Figure 1. Protein kinases The protein kinases belong to the great family of kinases and are responsible for the mechanism of phosphorylation. Table I Subfamilies of protein kinases. Protein kinase family Origin of the name Description Refs. They are important for expression of various genes because after activation, CAMKs phosphorylate several transcription factors.

Abnormalities in MAP kinase cascades are tightly linked to oncogenic transformation 23 GSK3, initially described as a key enzyme involved in glycogen metabolism, is now known to regulate a diverse array of functions. TKs are cell surface receptors RTKs and many of the others function close to the surface of the cell 19 TKL T yrosine k inase- l ike Tyrosine kinase-like kinases are serine-threonine protein kinases named so because of their close sequence similarity to tyrosine kinases.

Protein phosphatases Phosphatases have the opposite function of kinases. Activities and role of protein phosphorylation under physiological conditions Protein phosphorylation is one of the initial steps that is vital for the coordination of cellular and organic functions such as the regulation of metabolism, proliferation, apoptosis, subcellular trafficking, inflammation, and other important physiological processes.

Protein phosphorylation and cancer Phosphorylation is one of the most common PTMs involved in the regulation of multiple biological processes and overexpression of kinase. Figure 2. Protein kinases as drug targets The signaling pathways regulated by protein kinases contribute to the onset and progression of almost all types of cancer.

Conclusions Phosphoproteomics has a critical relevance for many aspects of biology and has a significant role for understanding the molecular mechanisms, especially those that lead to the genesis and growth of tumors 77 — References 1. Elucidating human phosphatase-substrate networks.

Sci Signal. The human phosphatase interactome: an intricate family portrait. FEBS Lett. In: Molecular Biology of the Cell. Anderson M, Granum S, editors. Hunter T. Why nature chose phosphate to modify proteins. Fukami Y, Lipmann F. Reversal of Rous sarcoma-specific immunoglobulin phosphorylation on tyrosine ADP as phosphate acceptor catalyzed by the src gene kinase.

Specific dephosphorylation of phosphoproteins by protein-serine and -tyrosine kinases. Roskoski R. Pharmacol Res. Protein kinase biochemistry and drug discovery. Bioorg Chem. Physicochemical mechanisms of protein regulation by phosphorylation. Front Genet.

Elsevier; Principles behind the multifarious control of signal transduction. FEBS J. Tonks NK. Protein tyrosine phosphatases: from genes, to function, to disease. Nat Rev Mol Cell Biol. Mathematical models of protein kinase signal transduction. Mol Cell. HuPho: the human phosphatase portal. PTP-central: a comprehensive resource of protein tyrosine phosphatases in eukaryotic genomes. Linear motif atlas for phosphorylation-dependent signaling. Tyrosine phosphorylation: thirty years and counting.

Curr Opin Cell Biol. Cancer Res. Jin J, Pawson T. Modular evolution of phosphorylation-based signalling systems. The nuts and bolts of AGC protein kinases. Analysis of CaM-kinase signaling in cells. Cell Calcium. Casein kinase I: another cog in the circadian clockworks. Chronobiol Int. Sundaram MV. WormBook: Cohen P, Goedert M. GSK3 inhibitors: development and therapeutic potential. Nat Rev Drug Discov. J Biol Chem. Cell Motil Cytoskeleton. A secreted Plasmodium falciparum kinase reveals a signature motif for classification of tyrosine kinase-like kinases.

Barford D. Trends Biochem Sci. Zhang ZY. Protein tyrosine phosphatases: structure and function, substrate specificity, and inhibitor development. Annu Rev Pharmacol Toxicol. Mackintosh C. Hardie GD, editor. TiO 2 -based phosphoproteomic analysis of the plasma membrane and the effects of phosphatase inhibitor treatment. J Proteome Res. Stern DF. Phosphoproteomics for oncology discovery and treatment.

Expert Opin Ther Targets. Liu Y, Chance MR. Integrating phosphoproteomics in systems biology. Comput Struct Biotechnol J.

Hurley, A. Dean, P. Thorsness, D. Koshland Jr. Hurley, P. Thorsness, V. Ramalingam, N. Helmers, D. Miller, L. Jensen, F. Diella et al. Pawson, G. Gish, and P. Hutti, E. Jarrell, J. Chang et al. View at: Google Scholar Z. Songyang and L. Mok, P. Kim, H. Lam et al. Brinkworth, A. Munn, and B.

Ellis and B. Cohen and A. Roy and M. Bollen, W. Peti, M. Ragusa, and M. Garaud and D. Walchli, X. Espanel, A. Harrenga, M. Rossi, G. Cesareni, and R. Flint, T. Tiganis, D. Barford, and N. View at: Google Scholar.